March 13, 2018
The direct-to-consumer genetic testing company, 23andMe, has received federal approval to inform people of breast cancer risk linked to three gene mutations—making it the first company allowed to test for cancer risk without a doctor’s prescription in the USA.
Source: Washington Post
https://www.washingtonpost.com/news/wonk/wp/2018/03/06/23andme-gets-fda-approval-to-report-breast-cancer-risk-without-a-doctor/?utm_term=.f7f86d0378be